Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH funded in full

This article was originally published in The Gray Sheet

Executive Summary

House passes the "Agriculture, Rural Development, Food & Drug Administration and Related Agencies Appropriations Act for FY 2006" (HR 2744) June 8, meeting the President's $221 mil. request for CDRH, which would fulfill the estimated MDUFMA funding target, assuming the enactment of "trigger-fix" legislation later this year (1"The Gray Sheet" Feb. 14, 2005, p. 3). Total FDA allotment of $1.5 bil. represents a $36 mil. increase over last year, but falls $14 mil. short of the President's request. An amendment proposed by Rep. Maurice Hinchey (D-N.Y.) and passing via a 218-210 vote would prohibit FDA from granting waivers to advisory panel participants harboring an apparent conflict of interest. Companion legislation is scheduled for mark-up by the Senate Appropriations/Agriculture, Rural Development & Related Agencies Subcommittee June 21 and by full committee June 23...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022225

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel